Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland, with additional offices in Boston, MA, and San Francisco, CA.
We focus almost exclusively on oncology therapeutics and on helping to drive value creation for our portfolio companies. We invest in the most promising drug discovery companies with the potential to create multiple medicines.
Our portfolio is focused throughout the US and Europe with investments from company inception to crossover rounds.
People
- Thilo Schroeder, Managing Partner
You last contacted this investor on .